Brainstem monoamine pathology of neonatal hypoxic-ischemic brain damage: A model of acute stage of neonatal asphyxia

Brain Research

Volumn 1213, Issue , 2008, Pages 120-126

  Shiraishi, Mika ^a,b   Takizawa, Yuji ^a   Ide, Shuhei ^a   Obonai, Toshimasa ^b   Goto, Yu ichi ^a   Itoh, Masayuki ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Brainstem; Model rat; Neonatal hypoxic ischemic encephalopathy; Norepinephrine; Serotonin

Indexed keywords

BRAIN MONOAMINE; NORADRENALIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN STEM; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; IMMUNOHISTOCHEMISTRY; NEUROTRANSMISSION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA NEONATORUM; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN STEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ELECTROCHEMISTRY; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA, BRAIN; IN SITU NICK-END LABELING; INFANT, NEWBORN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 44449085256     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.03.068     Document Type: Article

References (23)

1. Asakura H., Ichikawa H., Nakabayashi M., Ando K., Kaneko K., Kawabata M., Tani A., Satoh M., Takahashi K., and Sakamoto S. Perinatal risk factors related to neurologic outcomes of term newborns with asphyxia at birth: a prospective study. J. Obstet. Gynaecol. Res. 26 (2000) 313-324
2. Boulton A.A., and Eisenhofer G. Catecholamine metabolism: from molecular understanding to clinical diagnosis and treatment. Adv. Pharmacol. 42 (1998) 273-292
3. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical study. Synapse 23 (1996) 28-38
4. Brunner D., and Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann. N.Y. Acad. Sci. 836 (1997) 81-105
5. Hedner T., and Lundborg P. Regional changes in monoamine synthesis in the developing rat brain during hypoxia. Acta Physiol. Scand. 106 (1979) 139-143
6. Hedner T., and Lundborg P. Serotonin metabolism in neonatal rat brain during asphyxia and recovery. Acta Physiol. Scand. 109 (1980) 163-168
7. Hedner T., and Lundborg P. Catecholamine metabolism in neonatal rat brain during asphyxia and recovery. Acta Physiol. Scand. 109 (1980) 169-175
8. Ide S., Itoh M., and Goto Y. Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci. Lett. 386 (2005) 14-17
9. Lagercrantz H., and Bistoletti P. Catecholamine release in the newborn infant at birth. Pediatr. Res. 11 (1977) 889-893
10. Lipper E.G., Voorhies T.M., Ross G., Vannucci R.C., and Auld P.A. Early predictors of one-year outcome for infants asphyxiated at birth. Dev. Med. Child Neurol. 28 (1986) 303-309
11. Martín-Ancel A., García-Alix A., Pascual-Salcedo D., Cabañas F., Valcarce M., and Quero J. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 100 (1997) 789-794
12. Miyashita T., and Williams C.L. Glutamatergic transmission in the nucleus of the solitary tract modulates memory through influences on amygdala noradrenergic systems. Behav. Neurosci. 116 (2002) 13-21
13. Nestler E.J., Hyman S.E., and Malenka R.C. Catecholamines. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2001), The McGraw-Hill Companies, New York 167-190
14. Nestler E.J., Hyman S.E., and Malenka R.C. Serotonin, acetylcholine, and histamine. In Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2001), The McGraw-Hill Companies, New York 191-200
15. Ordway G.A., Stockmeier C.A., Cason G.W., and Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus ceruleus and raphe nuclei. J. Neurosci. 17 (1997) 1710-1719
16. Pearce W. Hypoxic regulation of the fetal cerebral circulation. J. Appl. Physiol. 100 (2006) 731-738
17. Pryds O., Greisen G., Lou H., and Friis-Hansen B. Vasoparalysis associated with brain damage in asphyxiated term infants. J. Pediatr. 117 (1990) 119-125
18. Rice J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9 (1981) 131-141
19. Rueter L.E., Fornal C.A., and Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev. Neurosci. 8 (1997) 117-137
20. Takase L.F., Nogueira M.I., Bland S.T., Baratta M., Watkins L.R., Maier S.F., Fornal C.A., and Jacobs B.L. Effect of number of tailshocks on learned helplessness and activation of serotonergic and noradrenergic neurons in the rat. Behav. Brain. Res. 162 (2005) 299-306
21. Takashima S., Hirayama A., Okoshi Y., and Itoh M. Vascular, axonal and glial pathogenesis of periventricular leukomalacia in fetuses and neonates. Neuroembryology 1 (2002) 72-77
22. Takeuchi Y., Fujiwara K., Ishimura K., Aoki S., Okano S., Yamazoe I., Yoshioka H., and Sawada T. Effects of neonatal asphyxia on the serotonin neuron system in the developing brain studied by immunohistochemistry. Dev. Neurosci. 14 (1992) 394-402
23. Williams C.L., Men D., and Clayton E.C. The effects of noradrenergic activation of the nucleus tracts solitarius on memory and in potentiating norepinephrine release in the amygdala. Behav. Neurosci. 114 (2000) 1131-1144